Patent · US Revoked

Detecting pancreatic high-grade dysplasia

US11047013B2 · kind B2 · utility

0Cited by
50References
7Claims
0Family size

Assignee

Inventors

Key dates

Filing dateApr 13, 2017
Grant dateJun 29, 2021
Priority date
Expiry dateMay 14, 2037

Classification

  • Technology area (CPC —)General

Abstract

Provided herein is technology for pancreatic high-grade dysplasia screening and particularly, but not exclusively, to methods, compositions, and related uses for detecting the presence of pancreatic high-grade dysplasia (IPMN-HGD, PanIN-3, or PDAC).

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.